zurück 2010/2011 | Archiv
2009
Ex vivo and in vivo evaluation of [18F]PR04.MZ in rodents: a selective dopamine transporter imaging agent. Riss PJ, Debus F, Hummerich R, Schmidt U, Schloss P, Lueddens H, Roesch F. (2009). ChemMedChem. 4(9):1480-7.
Synthesis and monoamine uptake inhibition of conformationally constrained 2beta-carbomethoxy-3beta-phenyl tropanes. Riss PJ, Hummerich R, Schloss P. (2009) Org Biomol Chem. 7(13):2688-98.
Monitoring mouse serotonin transporter internalization in stem cell-derived serotonergic neurons by confocal laser scanning microscopy. Lau T, Horschitz S, Bartsch D, Schloss P. (2009) Neurochem Int. 54(3-4):271-6.
Creatine transporter expression after antidepressant therapy in rats bred for learned helplessness. Lugenbiel P, Sartorius A, Vollmayr B, Schloss P. (2009) World J Biol Psychiatry. 25:1-5. 2008
The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons. Lau T and Schloss P.
Eur. J. Pharmacol. 14;578(2-3):137-41.
Glycine residues G338 and G342 are important determinants for serotonin transporter dimerisation and cell surface expression. Horschitz S, Lau T, Schloss P.
Neurochem Int. 52(4-5), 770-775.
Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons. Lau T, Horschitz S, Berger S, Bartsch D, Schloss P.
FASEB, 22(6), 1702-1714.
Proton magnetic resonance spectroscopic creatine correlates with creatine transporter protein density in rat brain. Sartorius A, Lugenbiel P, Mahlstedt MM, Ende G, Schloss P, Vollmayr B.
J Neurosci Methods. 172(2):215-219
Platelet surface P-selectin expression is highly correlated with serotonin transporter density in human subjects. Frankhauser P, Baranyai R, Ahrens T, Schloss P, Deuschle M, Lederbogen F.
Thromb Haemost. 100 (6): 1201-3
The dopamine agonism on ADP-stimulated platelets is mediated through D2-like but not D1-like dopamine receptors. Schedel A, Schloss P, Klüter H, Bugert P.
Naunyn Schmiedebergs Arch Pharmacol. 378(4):431-439. 2006
Characterization of the neuronal dopamine transporter DAT in human blood platelets. Frankhauser P, Grimmer Y, Bugert P, Deuschle M, Schmidt M, Schloss P.
Neurosci. Lett. 399, 197-201.
Inhibition of serotonin transport by (+)McN5652 is noncompetitive. Hummerich R, Schulze O, Rädler T, Mikecz OP, Reimold M, Brenner W, Clausen M, Schloss P, Buchert R.
J. Nuclear Medicine. 3, 317-323
Rapid and efficient differentiation of dopaminergic neurons from mouse embryonic stem cells. Lau T, Adam S, Schloss P.
Neuroreport, 17, 975-979.
Correlation between MR-spectroscopic rat hippocampal choline levels and phospholipase A2. Sartorius A, Schloss P, Vollmayr B, Ende G, Neumann-Haefelin C, Hoehn M, Henn FA.
World J. Biol. Psychiatry, 7, 246-250. 2005
A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression. Horschitz S, Hummerich R, Lau T, Rietschel M, Schloss P.
Mol. Psychiatry, 10, 1104-1109. 2004
New insights into the mechanisms of antidepressant therapy. Schloss P and Henn FA.
Pharmacol. Therapeutics, 102 (1), 47-60.
DASB -in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as positron emission tomography (PET) tracer. Hummerich R, Reischl G, Ehrlichmann W, Machulla HJ, Heinz A, Schloss P.
J Neurochem, 90, 1218-1226.
Gene-environment interaction in hyperkinetic conduct disorder (HD + CD) as indicated by season of birth variations in dopamine receptor (DRD4) gene polymorphism. Seeger G, Schloss P, Schmidt MH, Rüther-Jungfleisch A, Henn FA.
Neurosci. Lett., 366, 282-286. 2003
Functional coupling of serotonin and noradrenaline transporters. Horschitz S, Hummerich R, Schloss P.
J. Neurochem, 86, 958 - 965. 2001
Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor. Horschitz S, Hummerich R, Schloss P.
Neuroreport 12(10):2181-2184
Structure, function and regulation of the 5-hydroxytryptamine (serotonin) transporter. Horschitz S, Hummerich R, Schloss P.
Biochem Soc Trans. 29: 728-732
Membrane cholesterol modulates serotonin transporter activity. Scanlon SM, Williams DC, Schloss P.
Biochemistry. 40(35):10507-10513
Marker gene polymorphisms in hyperkinetic disorder--predictors of clinical response to treatment with methylphenidate? Seeger G, Schloss P, Schmidt MH.
Neurosci Lett. 313(1-2):45-48
Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders. Seeger G, Schloss P, Schmidt MH.
Mol. Psychiatry, 6(2):235-238
2000
Characterization of carrier-mediated efflux in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: a superfusion study. Sitte HH, Scholze P, Schloss P, Pifl C, Singer EA.
J Neurochem 74, 1317-1324
Acute stress decreases serotonin transporter mRNA in the raphe pontis but not in other raphe nuclei of the rat. Vollmayr B, Keck S, Henn FA, Schloss P.
Neurosci Lett 290, 109-112
|
